the staff of the Ridgewood blog
Ridgewood NJ, Lecanemab is the first drug to slow the destruction of the brain in Alzheimer’s. It attacks the beta amyloid that builds up in the brains of people with Alzheimer’s. Lecanemab only has a small effect and it only works in the early stages of the disease. Despite this, leading researchers are calling the findings ‘momentous’. Other therapies so far have had a 100% failure rate.